Photo taken from MedscapeLIVE/X
Apr 30, 2024, 18:17
Neeraj Agarwal: The latest in the mHSPC prostate cancer
Neeraj Agarwal shared a post by MedscapeLIVE, on X:
“The American Urological Association, AUA24, MedscapeLIVE meeting, Friday, May 3 (6pm CST). Join us in person or virtually to discuss the latest in the mHSPC prostat ecancer. Latest clinical data and emerging genomic targeted Rx.”
Quoting MedscapeLIVE‘s post:
“Master prostate cancer therapies! Dive into the latest agents, stay ahead with emerging data, and manage adverse events confidently. Elevate care with new insights in mHSPC treatment.“
Additional details.
Source: Neeraj Agarwal/X and MedscapeLIVE/X
Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI. Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25